F8 and hemophilia A: Previous studies have attempted to predict bleeding risk and annualized bleeding rate (ABR) in people with hemophilia A utilizing FVIII pharmacokinetic (PK) parameters, and reported an association between bleeding risk and peak FVIII level, area under the curve, and time per week with FVIII activity below 1 IU/dL.